Press release
Immunohistochemistry Market to Surpass US$ 3,585.31 million by 2028, Driven by Rising Cancer Diagnostics, Growing Biomarker Research, and Expanding Adoption of Precision Medicine Technologies, According to The Insight Partners
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006184?utm_source=OpenPR&utm_medium=10770
The Immunohistochemistry Market is projected to reach US$ 3,585.31 million by 2028 from US$ 2,171.61 million in 2021. The market is estimated to register a CAGR of 7.4% from 2021 to 2028.
Advancements in biomarker discovery, digital pathology, and automated staining technologies are transforming the diagnostic landscape. Immunohistochemistry Market News highlights a surge in product launches, strategic collaborations, acquisitions, and research investments aimed at improving diagnostic accuracy and laboratory efficiency.
The increasing focus on personalized medicine and targeted therapies is further strengthening the adoption of immunohistochemistry solutions across the healthcare and life sciences sectors.
What Factors Are Driving Growth in the Immunohistochemistry Market?
Several factors are contributing to the rapid growth of the Immunohistochemistry Market worldwide. One of the primary drivers is the increasing prevalence of cancer.
Immunohistochemistry has become an essential diagnostic tool for identifying tumor types, determining disease progression, and selecting appropriate treatment strategies.
The growing demand for personalized medicine is also supporting market growth. Healthcare providers are increasingly relying on biomarker-based diagnostics to tailor therapies according to individual patient profiles. Immunohistochemistry plays a crucial role in identifying molecular targets and supporting precision treatment approaches.
In addition, rising investments in healthcare infrastructure, expanding pathology laboratory networks, and increasing awareness regarding early disease detection are driving demand for advanced diagnostic technologies. The growing number of clinical research activities and drug development programs further enhances the need for reliable immunohistochemistry solutions.
How Are Recent Developments Influencing the Immunohistochemistry Market?
Recent developments are significantly reshaping the Immunohistochemistry Market. One of the most notable trends is the increasing adoption of automation technologies. Automated staining systems are improving laboratory productivity, reducing human errors, and ensuring consistent test results across healthcare settings.
Digital pathology integration is another important development transforming diagnostic workflows. Advanced imaging systems and artificial intelligence-based analysis platforms are enabling pathologists to interpret tissue samples more efficiently and accurately.
Explore full report: https://www.theinsightpartners.com/reports/immunohistochemistry-market
Strategic partnerships between biotechnology companies, diagnostic manufacturers, and research organizations are accelerating innovation in antibody development and biomarker identification. These collaborations are supporting the introduction of novel diagnostic assays that address emerging clinical needs.
Furthermore, increasing regulatory approvals for companion diagnostics and targeted therapies are creating new growth opportunities for immunohistochemistry products. As precision oncology continues to evolve, demand for advanced tissue-based diagnostic tools is expected to rise substantially.
Immunohistochemistry Market News and Recent Developments
Expansion of Automated Staining Systems
Manufacturers are introducing highly automated staining platforms that improve laboratory throughput and standardize testing procedures. These systems help reduce turnaround times while enhancing diagnostic reliability.
Growing Adoption of Digital Pathology
Digital pathology technologies are enabling remote consultation, image sharing, and artificial intelligence-assisted analysis. The integration of digital workflows is improving operational efficiency and supporting more accurate diagnoses.
Increased Focus on Biomarker Research
The identification of novel biomarkers is creating opportunities for new diagnostic applications. Research efforts focused on cancer biomarkers and targeted therapies continue to expand the scope of immunohistochemistry testing.
Strategic Collaborations and Acquisitions
Leading industry participants are engaging in partnerships, acquisitions, and research collaborations to strengthen product portfolios and accelerate innovation. These initiatives are enhancing market competitiveness and expanding global reach.
Key Players in the Immunohistochemistry Market
Major companies operating in the market include:
• F. Hoffmann-LA Roche AG
• Merck KGaA
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• Abcam Plc
• Agilent Technologies
• Bio SB
• Bio-Rad Laboratories
• Cell Signaling Technology, Inc.
• Danaher Corporation
These companies are actively investing in research and development, automation technologies, digital pathology solutions, and strategic partnerships to strengthen their market positions and address evolving diagnostic requirements.
Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPRE00006184?utm_source=OpenPR&utm_medium=10770
Future Outlook
The future of the Immunohistochemistry Market remains highly promising as healthcare systems increasingly adopt precision medicine and biomarker-driven diagnostic approaches. Advancements in digital pathology, artificial intelligence, automation, and companion diagnostics are expected to enhance diagnostic accuracy and laboratory efficiency.
The growing burden of cancer and chronic diseases, combined with increasing investments in healthcare infrastructure and life sciences research, will continue to drive market growth. Furthermore, the development of novel biomarkers and targeted therapies is likely to expand the role of immunohistochemistry in clinical decision-making and personalized treatment planning. As diagnostic technologies continue to evolve, immunohistochemistry will remain a critical tool in modern pathology and disease management.
Related Reports:
Bioprocessing Market- https://www.theinsightpartners.com/reports/bioprocessing-market
PCR Technologies Market- https://www.theinsightpartners.com/reports/pcr-technologies-market
Contact Us
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
About Us
The Insight Partners is a leading provider of actionable market intelligence and consulting services across various industries. Our research reports combine advanced analytics, expert insights, and reliable data to help organizations identify new opportunities, optimize strategies, and achieve sustainable growth. We specialize in delivering in-depth market studies covering healthcare, technology, manufacturing, and emerging sectors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunohistochemistry Market to Surpass US$ 3,585.31 million by 2028, Driven by Rising Cancer Diagnostics, Growing Biomarker Research, and Expanding Adoption of Precision Medicine Technologies, According to The Insight Partners here
News-ID: 4558326 • Views: …
More Releases from The Insight Partners
Armor Materials Market Demand, Share & Growth by 2034
Armor materials are specialized substances designed to protect individuals and assets from various forms of threats, including ballistic impacts, blasts, and other hazardous conditions. These materials are utilized in a wide range of applications, including personal protective equipment, military vehicles, aerospace components, and civil infrastructure. The demand for advanced armor solutions is driven by the need for enhanced safety and security in both military and civilian contexts.
To Get Sample Copy…
Plant based Foods Market Size is Expected to Reach US$ 112.98 Billion by 2034 fr …
The Plant based Foods Market is poised for remarkable growth, driven by increasing consumer awareness regarding health, sustainability, and ethical food choices. According to the latest market research by The Insight Partners, the Plant based Foods Market is projected to grow from US$ 50.40 Billion in 2025 to US$ 112.98 Billion by 2034, registering a CAGR of 9.38% during the forecast period from 2026 to 2034. The rising popularity of…
Multivitamin Tablets and Capsules Market to Reach US$ 49.37 Billion by 2034 at a …
The multivitamin tablets and capsules market is witnessing consistent growth, driven by rising consumer awareness regarding preventive healthcare, increasing demand for dietary supplements, and expanding health and wellness trends across developed and emerging economies. According to The Insight Partners, the global multivitamin tablets and capsules market size is projected to grow from US$ 34.99 billion in 2025 to US$ 49.37 billion by 2034, registering a CAGR of 3.90% during the…
Global Green (Vegetative) Roofing Market Worth US$ 12.46 Billion by 2034, Growin …
The global Green (Vegetative) Roofing Market is poised for remarkable growth as sustainability initiatives, urban greening programs, and energy-efficient construction practices continue to gain momentum worldwide. According to the latest market analysis by The Insight Partners, the market is expected to grow from US$ 3.14 billion in 2025 to US$ 12.46 billion by 2034, registering a robust CAGR of 16.54% during the forecast period of 2026-2034.
Get Sample Copy of Report…
More Releases for Immunohistochemistry
Top Factor Driving Immunohistochemistry (IHC) Market Growth in 2025: Increase In …
What market dynamics are playing a key role in accelerating the growth of the immunohistochemistry (ihc) market?
The immunohistochemistry (IHC) market is projected to grow due to the escalating occurrence of chronic illnesses. Chronic ailments are medical conditions that typically last for at least three months and can typically be managed but not completely cured. Immunohistochemistry proves beneficial in diagnosing such diseases including cancer, cardiovascular conditions, and others due to its…
Top Factor Driving Immunohistochemistry (IHC) Market Growth in 2025: Increase In …
What market dynamics are playing a key role in accelerating the growth of the immunohistochemistry (ihc) market?
The immunohistochemistry (IHC) market is projected to grow due to the escalating occurrence of chronic illnesses. Chronic ailments are medical conditions that typically last for at least three months and can typically be managed but not completely cured. Immunohistochemistry proves beneficial in diagnosing such diseases including cancer, cardiovascular conditions, and others due to its…
Immunohistochemistry Market Future Prediction Report By 2028
Immunohistochemistry Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Download…
How big is Immunohistochemistry Market?
The Global Immunohistochemistry Market size was valued at US$ 2,302.79 million in 2022 and is estimated to reach US$4,240.65 million by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Immunohistochemistry market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume…
Launch of new Immunohistochemistry Products will boost the Immunohistochemistry …
The research report “Global Immunohistochemistry Market: By Product Type (Antibodies (Primary Antibodies and Secondary Antibodies), Equipment (Tissue Microarrays, Tissue Processing Systems, Slide Scanners and Others) Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes and Diluents) and Kits) By Application (Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases) and Drug Testing) By Application (Hospitals & Diagnostic Laboratories, Research…
Global Immunohistochemistry (IHC): Markets 2019-2022
Press Release – 28 Jan 2019
Research and Development News --
. .
Latest Update "Immunohistochemistry (IHC): Global Markets to 2022" with Industries Survey | Global Current Growth and Future.
' '
Immunohistochemistry (IHC) is an umbrella term which combines immunological, biochemical and anatomical techniques to image and localize discrete components in tissues with the help of antibodiesantigen interaction. The use of IHC helps in the documentation and visualization of the high-resolution distribution of…
